http://www.forbes.com/feeds/afx/2009/08/18/afx6790084.html
<p>BANGALORE, Aug 18 (Reuters) – Stem cell research company Geron Corp said U.S. health regulators have placed a clinical hold on its investigational new drug application for a cell therapy to treat subacute spinal cord injury…</p>